AI-generated summary
In this small randomized pilot trial of 21 women with melasma, the authors compared amber light therapy with placebo cream against sham light therapy with tranexamic acid cream over 12 weeks. They report no significant differences in MASI or PGA scores, but both groups improved in quality of life, and the study was underpowered due to early termination.
- Participants
- 21
- Who or what was studied
- Women with melasma
- Limits stated in the abstract
- The study was underpowered (51% power) due to early termination and small sample size, and environmental temperatures during the study period may have confounded results.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Light-emitting diode, Randomized controlled trial, Trial registration, Primary outcome, Sample size, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.